StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report sent to investors on Saturday. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright upped their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
Read Our Latest Stock Report on SNES
SenesTech Price Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Quiet Period Expirations Explained
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What Makes a Stock a Good Dividend Stock?
- Nebius Group: The Rising Star in AI Infrastructure
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.